A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol

BACKGROUND: Postoperative thyroid stimulating hormone (TSH) suppression therapy is recommended for patients with intermediate- and high-risk differentiated thyroid cancer to prevent the recurrence of thyroid cancer. With the recent increase in small thyroid cancer cases, the extent of resection duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eun Kyung, Kang, Yea Eun, Park, Young Joo, Koo, Bon Seok, Chung, Ki-Wook, Ku, Eu Jeong, Won, Ho-Ryun, Yoo, Won Sang, Jeon, Eonju, Paek, Se Hyun, Lee, Yong Sang, Lim, Dong Mee, Suh, Yong Joon, Park, Ha Kyoung, Kim, Hyo-Jeong, Kim, Bo Hyun, Kim, Mijin, Kim, Sun Wook, Yi, Ka Hee, Park, Sue K., Jung, Eun-Jae, Choi, June Young, Bae, Ja Seong, Hong, Joon Hwa, Nam, Kee-Hyun, Lee, Young Ki, Yu, Hyeong Won, Go, Sujeong, Kang, Young Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258337/
https://www.ncbi.nlm.nih.gov/pubmed/34034365
http://dx.doi.org/10.3803/EnM.2020.943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258337/
https://www.ncbi.nlm.nih.gov/pubmed/34034365
http://dx.doi.org/10.3803/EnM.2020.943

Ejemplares similares